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Abstract
Background-: Mexican-Americans (MA) exhibit increases in various cardiovascular disease (CVD)
risk factors compared to non-Hispanic Whites (NHW), yet are reported to have lower CVD
mortality rates. Our aim was to help explain this apparent paradox by evaluating endothelial
function and urine albumin levels in MA and NHW.
Methods-: One hundred-five MA and 100 NHW adults were studied by brachial artery flow-
mediated dilatation (FMD), blood and urine tests. Participants were studied by ultrasound-
determined brachial artery flow-mediated dilatation (FMD), blood and urine tests, at a single visit.
Results-: Despite higher BMI and triglycerides in MA, MA demonstrated higher FMD than did
NHW (9.1 ± 7.3% vs. 7.1 ± 6.3%, p < 0.04). Among MA, urinary albumin was consistently lower in
participants with FMD ≥ 7% FMD versus < 7% FMD (p < 0.006). In multivariate analyses in MA men,
urinary albumin was inversely related to FMD (r = -0.26, p < 0.05), as were BMI and systolic blood
pressure. In MA women, urinary albumin:creatinine ratio was an independent inverse predictor of
FMD (p < 0.05 ).
Conclusion-: To our knowledge, this is the first study to analyze, in asymptomatic adults, the
relation of MA and NHW ethnicity to FMD and urine albumin levels. The findings confirm ethnic
differences in these important subclinical CVD measures.
Background
Mexican-Americans (MA) are known to exhibit increased
prevalence of various cardiovascular disease (CVD) risk
factors – e.g., obesity, hyperlipidemia and diabetes melli-
tus – compared to non-Hispanic whites (NHW), yet have
been reported to have lower CVD case fatality rates than
NHW [1-3]. Although endothelial dysfunction (ED) is
known to be an early marker of vascular disease-e.g.,
atherosclerosis-there is a lack of data examining ethnic
differences in ED between asymptomatic MA and NHW.
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that their finding of a greater hospitalized myocardial inf-
arction rate – in the face of reported lower coronary heart
disease (CHD) fatality rates among MA in vital statistics
studies – is likely due to a misclassification of cause of
death and/or ethnicity on death certificates [4]. However,
another possible explanation may be differences in degree
of subclinical CVD [5].
Flow-mediated dilatation (FMD) of the brachial artery
measured using ultrasound has been shown to be an early
predictor of the risk of developing CVD [2]. Microalbu-
minuria, also hypothesized to be related to vascular
endothelial function, has previously been described as the
earliest marker for the development of CHD in Type I dia-
betes mellitus [6]. The aim of this pilot study was to
obtain FMD and urinary albumin data in MA and NHW
that might help explain the apparent paradox in MA. The
hypotheses tested were: 1) There are significant differ-
ences in FMD between MA and NHW; these differences
relate to ethnic differences in the levels of traditional CHD
risk factors; and 2) FMD is associated with subclinical dis-




The study was conducted among asymptomatic commu-
nity-based adult volunteers. To qualify for inclusion, sub-
jects had to be classified as Mexican-American (MA)
according to at least one of the following criteria used in
the San Antonio Heart Study [7]: 1) Father's surname and
mother's maiden name are both Spanish, and both par-
ents were born in Mexico; and/or 2) Only one parent has
a Spanish surname, but three of four grandparents have
Mexican origins.
We studied 105 adult MA (42 men and 63 women, age 46
± 14 yrs) and 100 NHW (59 men and 41 women, age 50
± 11 yrs) volunteers using blood tests, transthoracic
echocardiography (echo), and brachial arterial flow-
mediated dilatation (FMD) by ultrasound. Subjects were
generally healthy: Individuals with hypertension or
known CVD, or taking cardiovascular or BP medications
were excluded.
Echocardiography
This study employed the echo protocol used in both the
Cardiovascular Health Study (CHS) [8] and Coronary
Artery Risk Development in Young Adults (CARDIA)
studies [9]. For each subject, a baseline echo was recorded
using a standardized protocol. Two-dimensionally guided
M-mode echo measurements of the LV and left atrium
were made according to conventions of the American
Society of Echocardiography. LV mass was derived from
the formula described by Devereux, et al. LV mass was
normalized for various body size measures, including
height [10].
Measurement of Flow-mediated Dilatation
A 7.0 or 10 MHz linear array ultrasound transducer was
used to image the right brachial artery 6 cm proximal to
the antecubital fossa. Scanning was performed in the lon-
gitudinal view with transmit (focal) zone set to the depth
of the arterial near-wall. After recording baseline images,
a right brachial artery BP cuff was inflated to 30 mmHg
above systolic pressure, occluding the artery for 4 minutes.
The right brachial cuff was then deflated rapidly to zero
pressure, resulting in reactive hyperemia. The arterial seg-
ment imaged at baseline was continuously imaged during
cuff inflation and for 3 minutes following deflation. Bra-
chial artery diameter after reactive hyperemia was
expressed as a percentage of resting diameter.
Blood/Urine Samples
Fasting venous blood samples were obtained for analysis
of serum electrolytes and creatinine; fasting total, HDL-,
and LDL-cholesterol and triglycerides; and glucose. A spot
urine was collected for albumin and creatinine determina-
tions.
Statistical Analysis
Data are presented as mean ± standard deviations or per-
centages. Group comparisons were performed using Stu-
dent's t-test for continuous variables and X2 test for
categorical variables. Due to a lack of data indicating an
appropriate percent cut-point for normal vs. abnormal
FMD in the MA population, the reported cut-point for
NHW (abnormal FMD < 7%) was examined in this study
[11-13].
Multiple linear regression analyses were performed to
identify risk factors simultaneously predictive of FMD.
Variables were selected for entry if the probability value
was < 0.10 in univariate testing of association. Modeling
was done using the selected factors as independent varia-
bles and FMD as dependent variables. The full set of
potential factors was considered with the forced entry
method. To examine whether ethnicity (MA vs. NHW)
remained significantly associated with FMD after adjust-
ing for cardiovascular risk factors, multivariate analyses
were conducted adjusting for parameters independently
related to FMD – e.g., BMI, age, gender, systolic BP, LDL-
cholesterol, brachial artery diameter, etc. – with and with-
out urinary albumin. Additional multivariate analyses
were performed using analysis of covariance (ANCOVA)
with estimated marginal means and main effect options
compared to determine the relation of urine albumin and
CVD risk factors to FMD. ANCOVA models were created
to assess the association between FMD and the variousPage 2 of 6
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age and risk factors. The effect of each risk factor with a sig-
nificant bivariate relationship to FMD was analyzed by
ANCOVA. Models were constructed by adjusting for age
(Model 1), age plus CVD risk factors (systolic BP, BMI,
LDL-cholesterol, HDL-cholesterol, triglycerides, glucose,
and current smoking) (Model 2), and age, CVD risk fac-
tors plus either urinary albumin (Model 3), or urine albu-
min:creatinine (Alb:Cr) ratio (Model 4).
Results and Discussion
Study participant demographic, risk factor, and subclini-
cal disease characteristics by ethnic group and gender are
presented in Table 1. BMI and serum triglycerides were
significantly higher in the overall MA versus the overall
NHW cohort, while age, LDL-cholesterol, serum creati-
nine, and percent current smokers were all significantly
lower in the MA than in the NHW cohort.
In the overall cohort, MA demonstrated higher FMD com-
pared to NHW (absolute diameter change: 0.0354 ± .02
cm vs 0.0280 ± 0.03 cm and % FMD: 9.1 ± 7.3% vs 7.1 ±
6.3%, respectively, both p < 0.04). Brachial artery baseline
diameters were similar in MA and NHW (0.389 ± 0.06
and 0.393 ± 0.07 cm, respectively).
Bivariate analyses
Bivariate analyses of the relationship between risk factor
and subclinical disease variables and FMD were per-
formed by ethnic-gender subgroup. Inverse relations were
noted between FMD and both BMI and height in the over-
all MA cohort (r = -0.205, p < 0.05 and r = -0.223, p < 0.05,
respectively), and also between FMD and height and
weight in the overall NHW cohort (r = -0.257, p < 0.01,
and r = -0.216, p < 0.05, respectively). In addition, in MA
men, FMD was inversely related to all body size measures,
whereas in NHW men, FMD was directly related to diasto-
lic BP and HDL-cholesterol.
Of additional interest, in MA men, an inverse relationship
was noted between urinary albumin and FMD (r = -0.26,
p < 0.05). In contrast, no significant relationship was
found between FMD and urinary albumin in MA women,
or in NHW men or women. Furthermore, in women in
both ethnic groups, no significant correlation was
observed between any of the continuous or categorical
variables and FMD-except for an inverse relation between
Alb:Cr ratio and FMD in MA women.
Study participants were further subgrouped based on eth-
nicity, gender and FMD values (FMD ≥ 7% vs FMD < 7%).
LV mass in the overall MA cohort with FMD ≥ 7% was sig-
nificantly lower than in the overall NHW cohort with
FMD ≥ 7% (p = 0.03), and lower in MA with FMD < 7%
compared with NHW participants with FMD < 7%. Uri-
nary albumin values were lower in the overall MA cohort
than in the overall NHW cohort and in MA women with
FMD% ≥ 7 than in MA women with FMD < 7% (0.61 ± 0.7
Table 1: Distribution of flow-mediated dilatation, and demographic and cardiovascular risk factors among Mexican-American (MA) 
and non-Hispanic white (NHW) cohorts of men and women
Overall Men Women
Mean ± SD Mean ± SD Mean ± SD
Parameter MA (N = 105) NHW (N = 100) MA (N = 39) NHW (N = 59) MA (N = 66) NHW (N = 41)
Risk Factors
Age (yrs) 46 ± 13.5 49.6 ± 10.8* 46.3 ± 13.6 47.7 ± 11.3 45.9 ± 13.6 52.4 ± 9.5**
Body Mass Index (kg/m2) 30.3 + 7.1 27.8 + 4.2** 30.9 ± 6.1 28.4 ± 3.5** 29.98 ± 7.6 26.9 ± 4.95*
Triglycerides (mg/dl) 172.6 ± 115.9 124.9 ± 66.6** 184.7 ± 92 135.7 ± 71** 166 ± 126.9 109.4 ± 56.2**
LDL cholesterol (mg/dl) 110.7 ± 29.4 123.5 ± 30.4** 112.8 ± 27.7 127.5 ± 27.7** 109.5 ± 30.4 117.8 ± 33.5
HDL cholesterol (mg/dl) 53.6 + 13.9 53.7 + 12.8 45.5 + 6 48.8 + 10* 57.9 + 14.2 60.9 + 12.6
Total Cholesterol (mg/dl) 198.7 ± 35.9 203.5 ± 37.5 195.6 ± 33.1 205.5 ± 37.9 200.3 ± 37.4 200.6 + 37.2
Systolic BP (mmHg) 124.5 ± 17.4 125.2 ± 14.4 129 ± 12.9 127.4 ± 13.4 121.9 ± 19 122.1 ± 15.4
Diastolic BP (mm Hg) 72.3 ± 10.6 74.6 ± 9.8 79.1 ± 9.9 77.4 ± 9.9 68.5 ± 9 70.5 ± 8.3
Serum Glucose (mg/dl) 90.8 ± 13.4 88.7 ± 21.7* 91.7 ± 13.1 91.2 ± 26.6 90.3 ± 13.7 85 ± 10.8*
Serum Creatinine (mg/dl) 0.8 ± 0.2 0.9 ± 0.2** 0.94 ± 0.1 0.98 ± 0.1* 0.73 ± 0.1 0.8 ± 0.1**
Urinary albumin (mg/dl) 0.88 ± 0.85 1.1 ± 2.3 0.9 ± 0.9 1.3 ± 2.9 1.1 ± 1.1 0.5 ± 0.3**
Brachial Artery Baseline
Diameter (cm) 0.389 ± 0.06 0.393 ± 0.07 0.41 ± 0.05 0.418 ± 0.04 0.322 ± 0.04 0.32 ± 0.05
Non-smokers (%) 65% 39%** 19% 27% 46% 14%**
Current smokers (%) 35% 61%** 16% 33% 19% 26%
Subclinical Disease
Flow-mediated Dilatation % 9.1 ± 7.3 7.1 ± 6.3* 8.7 ± 6.6 6.6 ± 4.1 9.2 ± 7.4 8.9 ± 7.3
*: p < 0.05; **: p < 0.01. P values represent the comparison between MA vs NHW for overall, men and women cohort. Abbreviations: LDL: low 
density lipoprotein; HDL: high density lipoprotein.Page 3 of 6
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0.006 and 0.05, respectively). In contrast, there was no
significant relation between urinary albumin levels and
FMD < 7 vs ≥ 7% in the NHW cohort (0.76 ± 1.2 vs 0.69
± 0.5 mg/dl).
The relationship between FMD and urinary albumin is
displayed in Figure 1 for MA versus NHW men and for MA
versus NHW women. Overall, FMD in MA and NHW men
and women decreased as urinary albumin levels
increased. Among women with urinary albumin levels of
1.1–1.5 mg/dl, FMD was significantly higher in MA than
in NHW women (p < 0.05) (Figure 1). In MA men with
urinary albumin levels of 0–0.5 mg/dl, FMD trended
higher than in NHW men with the same albumin levels (p
< 0.08). Meanwhile, in MA men with urinary albumin lev-
els of 0.0–0.5 mg/dl, FMD was nearly significantly higher
than in MA men with urinary levels of 0.6–1.0 mg/dl (p <
0.06). In NHW men with urinary albumin levels of 0–0.5
mg/dl, FMD trended higher than in NHW men with uri-
nary albumin levels of 1.1–1.5 mg/dl (p = 0.054).
Multiple linear regression
In MA men, BMI, systolic BP and urine albumin were pre-
dictor variables and inversely related to FMD. After age,
brachial artery baseline diameter, BMI, systolic BP, LDL-
cholesterol, HDL-cholesterol, triglycerides, glucose, and
current smoking were forced into the multiple linear
regression model, the inverse association of FMD and uri-
nary albumin persisted (Table 2). In MA women, BMI, urine
albumin and Alb:Cr ratio (β = -0.140, -28.57, and β = -
0.211, respectively) were the most important predictor
variables, and inversely related to FMD (all p < 0.05).
After forcing the other variables listed above into the
model, an inverse association of FMD to Alb:Cr ratio per-
sisted in MA women (p < 0.05). In NHW men, only BMI
and HDL-cholesterol were positive predictors of FMD,
while in NHW women, only age and BMI were predictor
variables, and inversely related, to FMD. In both NHW
men and women participants, urinary albumin and
Alb:Cr ratio were not associated with FMD after entering
the above variables (Table 2).
ANCOVA analyses
FMD was significantly higher in MA compared with NHW
individuals. Of interest, after adjustment for age alone,
age plus CVD risk factors and brachial artery baseline
diameter or age, CVD risk factors plus albumin or plus
Alb:Cr ratio, FMD was not found to be significantly differ-
ent between MA and NHW men or between MA and NHW
women. After adjusting for age, CVD risk factors plus uri-
nary albumin, FMD was significantly higher only in MA
men compared to NHW men (7.8 ± 6.4% vs. 5.6 ± 4.5%,
p < 0.04). Alb:Cr ratio was not significantly associated
with FMD in either cohort.
FMD has been reported to be useful to assess long-term
CVD risk in high-risk and lower-risk populations, and to
predict short-term postoperative CVD event risk in a high-
risk population [14,15]. Endothelial function in normal
healthy adults is influenced by variables such as race
[11,14], age [13,14,16], and prandial state [17]. In healthy
people, endothelial function, as measured by FMD, has
been reported to be in the range of 7 to 10% (mean) [11-
14], but in patients with CVD, FMD is impaired or absent,
with FMD values ranging from 0 to 5%.
In our study, the MA cohort demonstrated significantly
higher FMD in comparison with the NHW cohort (9.1 ±
7.3% vs 7.1 ± 6.3%, p < 0.04). These findings are of inter-
est in view of a report from Bild and co-workers that the
prevalence of CAC, measured from computed tomo-
graphic (CT) scanning, was lower in a Hispanic (55.6%)
compared to a non-Hispanic Caucasian (70.4%) cohort5.
Ethnic differences in endothelium-dependent FMD have
also been observed in Chinese subjects, compared to
white subjects from Australia [18], and in Indian Asians in
the United Kingdom compared with European whites
[16].
Our findings of increased FMD in asymptomatic MA ver-
sus NHW, with no significant ethnic differences in base-
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factors – e.g., an increase in eNOS activity in the MA ver-
sus the NHW cohort, the presence of cohort differences in
other non-evaluated CHD risk factor(s) or biomarkers
which also modulate endothelial function, other environ-
mental or dietary factors, or perhaps genetic differences. A
consistent, but non-significant increase in % FMD in both
MA and NHW women, versus MA and NHW men, may be
due to smaller BA diameters in women than men (Table
1).
FMD has been shown previously to be decreased in obese
individuals [19]. In our study, FMD was lower in the
asymptomatic MA cohort and was inversely associated
with BMI. In contrast, there was no such association in
NHW. This inverse relation between BMI and FMD in His-
panics is similar to a previous report [18].
Impaired vasodilatation of vascular endothelium (which
predates atherosclerotic deposition) has been observed in
apparently healthy patients with risk factors for CHD,
including type 2 diabetes mellitus, but normoalbuminu-
ria [20,21]. It has been suggested that endothelial dys-
function may be an earlier predictor than urinary albumin
of the development of CHD and cardiovascular risk
[21,22]. Nonetheless, higher urinary albumin values, even
at levels below clinical microalbuminuria, are generally
associated with several measures of subclinical CVD in
adults without established CVD [20,23,24].
In our MA, but not our NHW cohort, urinary albumin lev-
els were consistently higher in subjects with FMD < 7%
versus those with FMD ≥ 7%. Urinary albumin levels were
the only predictor (inverse) in multivariate analyses of
FMD in MA men, while urinary Alb:Cr ratio was an
inverse predictor of FMD in MA women. Of interest, in
patients with persistent microalbuminuria, FMD has been
reported to be significantly less in Caucasians than in Afri-
can-Americans [17].
Limitations
The sample size of our pilot study was relatively small,
and a substantial proportion of the variability of brachial
FMD in our cohort remains unexplained by standard CVD
risk factors. A larger sample size might have helped to bet-
ter characterize the contribution of race/ethnicity to FMD
variability. The lack of an automated system for FMD
analysis may be an added limitation in the study.
Conclusion
To our knowledge, this is the first study to analyze, in
asymptomatic adults, the relation of MA and NHW ethnic-
ity to FMD and urinary albumin levels. Overall, our MA
cohort demonstrated higher FMD compared to the NHW
cohort. Our results are consistent with growing evidence
that risk factors contribute to the development of CVD, at
least in part, by impairing endothelial function. Longitu-
dinal follow-up of MA and NHW cohorts should help
determine whether endothelial dysfunction, as measured
by FMD, and urinary albumin provide additional value in
predicting CVD outcomes in additional to traditional risk
factors.
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